leadf
logo-loader
viewInnovaDerma PLC

InnovaDerma PLC's growth trajectory 'very much back on track'

Capital Network's Ed Stacey discusses InnovaDerma (LON:IDP) following the release of their results for the year to the end of June 2018.

These were in line with market expectations, with 21% like-for-like revenue growth.

InnovaDerma specialises in the development, manufacture and marketing of clinically proven products in life sciences, beauty, and personal care.

Quick facts: InnovaDerma PLC

Price: 52.5 GBX

LSE:IDP
Market: LSE
Market Cap: £7.61 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of InnovaDerma PLC named herein, including the promotion by the Company of InnovaDerma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Capital Network's analyst Ed Stacey on Innovaderma's strong growth drivers...

Analyst Ed Stacey talks investors through InnovaDerma (LON:IDP) reported results on 21 February for the first half of the full year (FY) to June 2019. Results were in line with January's trading statement, with first half (H1) revenues down 7.5% driven by disruptions to the direct-to-consumer...

on 27/2/19

2 min read